Innovations in the treatment of psoriasis.
Lebwohl
Mark
M
Department of Dermatology, The Mount Sinai School of Medicine, New York, NY 10029, USA. LebwohL@aol.com
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab